← Association for Accessible Medicines
FDANonrulemakingFDA-2023-D-4177

Quality Considerations for Topical Ophthalmic Drug Products; Draft Guidance for Industry; Availability

RIN
—
Last modified
Feb 4, 2025
Comment window
closed 883d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Feb 27, 2024 and Feb 27, 2024. 1 other organizations filed here. The comment window closed 883d ago.

What Association for Accessible Medicines filed (1)

Feb 27, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2023-D-4177-0039

FDA, Please find attached comments from The Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-D-4177, " Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability." Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, Association for Accessible Medicines

View on regulations.gov →

Abstract

OPEN

View on regulations.gov →

Co-filers (1)

See everyone who commented →